Tagged with Policy

Gilead Switzerland’s Stuart Head on Access, MFN & Valuing Innovation
What Hong Kong’s First-Ever Five-Year Plan Means for Biopharma
Randall “Randy” Rutta  – CEO, National Health Council
Michala Fischer-Hansen – EVP & Head of Europe & International Markets, Lundbeck
Joshua Salsi – Head of North America, Biocon Biologics
Scott Weintraub – SVP US Business, Alexion, AstraZeneca Rare Disease
Keren Haruvi – President, Sandoz North America
Alexander Natz – Secretary General, EUCOPE
5 Key US Pharma Industry Trends to Watch In 2026
Paul Kim – Principal, Kendall Square Policy Strategies
Christine Baeder – President USA & LATAM, Apotex
Lo Yuk Lam – President, HK Bio-Med Innotech Association
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here